CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
+6.24%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$688M
AUM Growth
+$86.5M
(+14%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
64.99%
Holding
134
New
47
Increased
52
Reduced
18
Closed
1
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 3.27% |
| 2 | Consumer Discretionary | 0.87% |
| 3 | Communication Services | 0.83% |
| 4 | Financials | 0.47% |
| 5 | Healthcare | 0.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Zoetis
ZTS
$67.5B
| $230K | 0.03% |
+943
| New | +$230K |
|
127
McCormick & Company Non-Voting
MKC
$18.8B
| $218K | 0.03% |
+2,256
| New | +$218K |
|
128
Palo Alto Networks
PANW
$128B
| $214K | 0.03% |
+2,310
| New | +$214K |
|
129
Danaher
DHR
$140B
| $202K | 0.03% |
+690
| New | +$202K |
|
130
Philip Morris
PM
$252B
| $202K | 0.03% |
2,126
| – | – |
|
131
Marathon Petroleum
MPC
$54.6B
| $201K | 0.03% |
+3,140
| New | +$201K |
|
132
Nuveen Quality Municipal Income Fund
NAD
$2.64B
| $161K | 0.02% |
+10,000
| New | +$161K |
|
|
EVFM
133
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| – | – |
-3,333
| Closed | -$37K |
|